Catarina Brito has led the Advanced Cell Models Laboratory of ITQB NOVA and iBET (PT) since 2014. Brito’s Lab focuses on microenvironment-driven modulation of disease progression and targeted therapy response through the development and interrogation of in vitro and ex vivo models of the disease microenvironment. The group has pioneered cell-based strategies to tackle the areas of cancer immunotherapies and viral vector-based gene therapies.